183 related articles for article (PubMed ID: 31733337)
1. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
[TBL] [Abstract][Full Text] [Related]
2. Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene.
Fujihira H; Masahara-Negishi Y; Tamura M; Huang C; Harada Y; Wakana S; Takakura D; Kawasaki N; Taniguchi N; Kondoh G; Yamashita T; Funakoshi Y; Suzuki T
PLoS Genet; 2017 Apr; 13(4):e1006696. PubMed ID: 28426790
[TBL] [Abstract][Full Text] [Related]
3. Ngly1 -/- rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems.
Asahina M; Fujinawa R; Nakamura S; Yokoyama K; Tozawa R; Suzuki T
Hum Mol Genet; 2020 Jun; 29(10):1635-1647. PubMed ID: 32259258
[TBL] [Abstract][Full Text] [Related]
4. A conserved role for AMP-activated protein kinase in NGLY1 deficiency.
Han SY; Pandey A; Moore T; Galeone A; Duraine L; Cowan TM; Jafar-Nejad H
PLoS Genet; 2020 Dec; 16(12):e1009258. PubMed ID: 33315951
[TBL] [Abstract][Full Text] [Related]
5. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
Suzuki T; Huang C; Fujihira H
Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
[TBL] [Abstract][Full Text] [Related]
6. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
Tambe MA; Ng BG; Freeze HH
Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
[TBL] [Abstract][Full Text] [Related]
7. A
Talsness DM; Owings KG; Coelho E; Mercenne G; Pleinis JM; Partha R; Hope KA; Zuberi AR; Clark NL; Lutz CM; Rodan AR; Chow CY
Elife; 2020 Dec; 9():. PubMed ID: 33315011
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Owings KG; Lowry JB; Bi Y; Might M; Chow CY
Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
Miao X; Wu J; Chen H; Lu G
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
[TBL] [Abstract][Full Text] [Related]
10. NGLY1 Deficiency, a Congenital Disorder of Deglycosylation: From Disease Gene Function to Pathophysiology.
Pandey A; Adams JM; Han SY; Jafar-Nejad H
Cells; 2022 Mar; 11(7):. PubMed ID: 35406718
[No Abstract] [Full Text] [Related]
11. Physiological importance of NGLY1, as revealed by rodent model analyses.
Fujihira H; Asahina M; Suzuki T
J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells.
Hetz R; Magaway C; Everett J; Li L; Willard BB; Freeze HH; He P
Biochem Biophys Res Commun; 2022 Dec; 632():165-172. PubMed ID: 36209585
[TBL] [Abstract][Full Text] [Related]
13. Defects in the Neuroendocrine Axis Contribute to Global Development Delay in a
Rodriguez TP; Mast JD; Hartl T; Lee T; Sand P; Perlstein EO
G3 (Bethesda); 2018 Jul; 8(7):2193-2204. PubMed ID: 29735526
[TBL] [Abstract][Full Text] [Related]
14. Ever-expanding NGLY1 biology.
Suzuki T; Yoshida Y
J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
[TBL] [Abstract][Full Text] [Related]
15. Loss of peptide:
Yoshida Y; Asahina M; Murakami A; Kawawaki J; Yoshida M; Fujinawa R; Iwai K; Tozawa R; Matsuda N; Tanaka K; Suzuki T
Proc Natl Acad Sci U S A; 2021 Jul; 118(27):. PubMed ID: 34215698
[TBL] [Abstract][Full Text] [Related]
16. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
[TBL] [Abstract][Full Text] [Related]
17. Drug screens of
Iyer S; Mast JD; Tsang H; Rodriguez TP; DiPrimio N; Prangley M; Sam FS; Parton Z; Perlstein EO
Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31615832
[No Abstract] [Full Text] [Related]
18. Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease.
Bi Y; Might M; Vankayalapati H; Kuberan B
Bioorg Med Chem Lett; 2017 Jul; 27(13):2962-2966. PubMed ID: 28512024
[TBL] [Abstract][Full Text] [Related]
19. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
Suzuki T
J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
[TBL] [Abstract][Full Text] [Related]
20. GlcNAc-Asn is a biomarker for NGLY1 deficiency.
Mueller WF; Zhu L; Tan B; Dwight S; Beahm B; Wilsey M; Wechsler T; Mak J; Cowan T; Pritchett J; Taylor E; Crawford BE
J Biochem; 2022 Feb; 171(2):177-186. PubMed ID: 34697629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
